Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025Cancer Treatment and Research CommunicationsOpen Access

CRISPR-mediated modulation of EGFR signaling in lung cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

MTMobina TabibianEMElahe MotevaseliSGSoudeh Ghafouri‐Fard

Discussion

Loading...

Member takes

Overview

Observational analysis demonstrates modulation of EGFR signaling in lung cancer, suggesting new therapeutic strategies.

Key Points

  • Modulating EGFR signaling could improve the treatment of lung cancer.
  • Application of CRISPR/Cas9 in lung cancer shows promise for overcoming resistance to prior therapies.
  • This research utilizes a CRISPR approach to target EGFR mutations associated with poor prognosis.
  • Exploring CRISPR technology may enable novel strategies for lung cancer treatment.

Cite This Study

Tabibian et al. (2025) studied this question.

synapsesocial.com/papers/68c2443bb210217d647aa310https://doi.org/10.1016/j.ctarc.2025.100992
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1CRISPR-BASED APPROACHES FOR THE DETECTION AND TARGETING OF LUNG CANCER BIOMARKERS: A NEW ERA IN PRECISION ONCOLOGY2025
  2. 2Cell Death, Molecular Targeted Therapies, and Metabolic Reprogramming in EGFR-Mutant Lung Cancer2025
  3. 3Personalized care for patients with EGFR‐mutant nonsmall cell lung cancer: Navigating early to advanced disease management2025 · 21 citations
  4. 4EGFR-Directed Tyrosine Kinase Inhibitors for Non-Small Cell Lung Cancer2025
  5. 5Lung Cancer in the Era of Precision Oncology2025